<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been found that the drug sermion (nicergoline)--a synthetic <z:chebi fb="0" ids="23943">ergot alkaloid</z:chebi> with alpha-adrenoblocking action--produces a pronounced vasoactive (spasmolytic) effect in the elderly patients suffering of initial atherosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A course of sermion treatment improves, via its effect on the brain and lower extremity vessels, the flow in most involved vascular regions </plain></SENT>
<SENT sid="2" pm="."><plain>High concentrations of the drug after intravenous administration of 4 mg of sermion (nicergoline) result in a rise of the sympathetic vascular tone, high adrenoblocking action </plain></SENT>
</text></document>